Home Cart Sign in  
Chemical Structure| 27740-01-8 Chemical Structure| 27740-01-8

Structure of Scutellarin
CAS No.: 27740-01-8

Chemical Structure| 27740-01-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Scutellarin is an active flavonoid that shows anti-tumor activity and anti-proteasome action. It can be isolated from the root of Scutellaria baicalensis Georgi.

Synonyms: Scutellarein 7-O-β-D-glucuronide; Breviscapine; Scutellarein-7-glucuronide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Scutellarin

CAS No. :27740-01-8
Formula : C21H18O12
M.W : 462.36
SMILES Code : O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C(O)C(O)=C3C(C=C(C4=CC=C(O)C=C4)OC3=C2)=O
Synonyms :
Scutellarein 7-O-β-D-glucuronide; Breviscapine; Scutellarein-7-glucuronide
MDL No. :MFCD01861503
InChI Key :DJSISFGPUUYILV-ZFORQUDYSA-N
Pubchem ID :185617

Safety of Scutellarin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Scutellarin

JAK-STAT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SK-N-SH cells 0.01, 0.1, 1, 10 μM 4 h Significantly enhanced the cell viability of the experimental model cells, indicating a substantial protective effect against NaN3-induced mitochondrial damage Adv Sci (Weinh). 2023 Nov;10(32):e2303584.
RLE-6TN cells 0.1, 0.2, 0.4 mM 24 or 48 h Scutellarin inhibited BLM-induced pulmonary fibrosis by suppressing the NF-κB/NLRP3 signaling pathway, reducing inflammation and epithelial-mesenchymal transition (EMT). Cell Death Dis. 2020 Nov 13;11(11):978.
A549 cells 0.1, 0.2, 0.4 mM 24 or 48 h Scutellarin inhibited BLM-induced pulmonary fibrosis by suppressing the NF-κB/NLRP3 signaling pathway, reducing inflammation and epithelial-mesenchymal transition (EMT). Cell Death Dis. 2020 Nov 13;11(11):978.
Human umbilical vein endothelial cells (HUVECs) 5, 20 μM 24 h SC rescued the TNFα-induced decrease in VE-cadherin, occludin, and CD31 expression and reduced FITC-dextran leakage through the endothelial monolayer. Acta Pharmacol Sin. 2022 Oct;43(10):2666-2677.
Human mammary microvascular endothelial cells (HMMECs) 5, 20 μM 24 h SC rescued the TNFα-induced decrease in VE-cadherin, occludin, and CD31 expression and reduced FITC-dextran leakage through the endothelial monolayer. Acta Pharmacol Sin. 2022 Oct;43(10):2666-2677.
Huh7 cells 5 μM 48 h Scu significantly inhibited colony formation, induced cell cycle arrest, and inhibited migration in Huh7 cells. Cell Death Dis. 2024 Apr 15;15(4):267.
HepG2 cells 5 μM 48 h Scu significantly inhibited colony formation, induced cell cycle arrest, and inhibited migration in HepG2 cells. Cell Death Dis. 2024 Apr 15;15(4):267.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LPS-induced sepsis model Intraperitoneal injection 100 mg/kg Single dose Inhibited LPS-induced serum IL-1β levels Acta Pharm Sin B. 2021 Jan;11(1):112-126
Sprague-Dawley rats Chronic Cerebral Hypoperfusion (CCH) model 100 mg/kg Scutellarin significantly improved learning and memory ability in the CCH model rats, alleviated oxidative stress injury, and restored mitochondrial function Adv Sci (Weinh). 2023 Nov;10(32):e2303584.
BALB/c mice BLM-induced pulmonary fibrosis model Intragastric administration 30, 60, 90 mg/kg Once per day for 14 or 28 days Scutellarin ameliorated BLM-induced pulmonary fibrosis by inhibiting the NF-κB/NLRP3 signaling pathway, reducing inflammation and epithelial-mesenchymal transition (EMT). Cell Death Dis. 2020 Nov 13;11(11):978.
Nude and Balb/c mice Triple-negative breast cancer (TNBC) model Intragastric administration 1, 10 mg/kg Consecutively for 2 months SC significantly suppressed TNBC metastasis and alleviated tumor-associated vascular endothelial barrier injury in vivo. Acta Pharmacol Sin. 2022 Oct;43(10):2666-2677.
BALB/c mice H22 xenograft model Intraperitoneal injection 60 and 100 mg/kg Once daily for four weeks Scu significantly inhibited the growth of H22 xenografts and increased immune cell infiltration in the tumors. Cell Death Dis. 2024 Apr 15;15(4):267.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.16mL

0.43mL

0.22mL

10.81mL

2.16mL

1.08mL

21.63mL

4.33mL

2.16mL

References

 

Historical Records

Categories